We are live on ! Find out more
TRIM

Thompson Rubinstein Investment Management Portfolio holdings

AUM $311M
1-Year Est. Return 11.71%
This Fund
S&P 500
This Quarter Est. Return
+2.64%
1 Year Est. Return
+11.71%
3 Year Est. Return
+42.77%
5 Year Est. Return
+48.6%
10 Year Est. Return
AUM
$299M
AUM Growth
+$5.31M
Cap. Flow
+$310K
Cap. Flow %
0.1%
Top 10 Hldgs %
38.7%
Holding
77
New
Increased
9
Reduced
38
Closed

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$922K
2
KR icon
Kroger
KR
+$572K
3
CVS icon
CVS Health
CVS
+$454K
4
NVS icon
Novartis
NVS
+$446K
5
IBM icon
IBM
IBM
+$341K

Top Sells

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$528K
2
INTC icon
Intel
INTC
+$156K
3
AAPL icon
Apple
AAPL
+$150K
4
KMPR icon
Kemper
KMPR
+$141K
5
COLM icon
Columbia Sportswear
COLM
+$139K

Sector Composition

Rank Sector Weight
1 Healthcare 26.79%
2 Industrials 20.86%
3 Technology 18.54%
4 Energy 9.53%
5 Consumer Staples 8.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCAR icon
1
PACCAR
PCAR
$69.4B
$17.5M 5.86%
424,457
AAPL icon
2
Apple
AAPL
$4.94T
$14M 4.67%
301,960
-3,300
-1% -$150K
HD icon
3
Home Depot
HD
$337B
$13.9M 4.63%
71,078
INTC icon
4
Intel
INTC
$453B
$13M 4.35%
261,867
-2,930
-1% -$156K
COST icon
5
Costco
COST
$422B
$11.2M 3.75%
53,718
WWD icon
6
Woodward
WWD
$24.5B
$9.92M 3.32%
129,062
BIIB icon
7
Biogen
BIIB
$29.8B
$9.7M 3.24%
33,409
-345
-1% -$97K
WBA
8
DELISTED
Walgreens Boots Alliance
WBA
$9.42M 3.15%
156,916
+576
+0.4% +$37.1K
JNJ icon
9
Johnson & Johnson
JNJ
$647B
$8.6M 2.87%
70,850
-717
-1% -$89.5K
MSFT icon
10
Microsoft
MSFT
$2.91T
$8.55M 2.86%
86,716
-1,000
-1% -$96.9K
HUBB icon
11
Hubbell
HUBB
$25.5B
$8.28M 2.77%
78,291
-130
-0.2% -$14.4K
WAT icon
12
Waters Corp
WAT
$36.5B
$8.12M 2.71%
41,952
ABBV icon
13
AbbVie
ABBV
$458B
$7.69M 2.57%
83,033
-1,124
-1% -$110K
DE icon
14
Deere & Co
DE
$166B
$7.13M 2.38%
50,979
-520
-1% -$76.6K
FLIR
15
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$6.58M 2.2%
126,643
-2,000
-2% -$107K
SLB icon
16
SLB Ltd
SLB
$77.6B
$6.29M 2.1%
93,850
+65
+0.1% +$4.46K
NVS icon
17
Novartis
NVS
$298B
$6.14M 2.05%
90,648
+6,466
+8% +$446K
PEP icon
18
PepsiCo
PEP
$191B
$5.95M 1.99%
54,665
IBM icon
19
IBM
IBM
$204B
$5.85M 1.95%
43,797
+2,443
+6% +$341K
XOM icon
20
ExxonMobil
XOM
$641B
$5.54M 1.85%
66,949
AEGN
21
DELISTED
Aegion Corp
AEGN
$5.49M 1.83%
213,134
-3,164
-1% -$78.5K
ADP icon
22
Automatic Data Processing
ADP
$103B
$5.17M 1.73%
38,529
-125
-0.3% -$15.8K
SYK icon
23
Stryker
SYK
$129B
$4.97M 1.66%
29,429
-75
-0.3% -$12.6K
CSCO icon
24
Cisco
CSCO
$448B
$4.74M 1.58%
110,031
-2,000
-2% -$87.4K
EMR icon
25
Emerson Electric
EMR
$82.7B
$4.68M 1.57%
67,727
-1,068
-2% -$75.1K

Similar funds

Thompson Rubinstein Investment Management's Q2 2018 Portfolio in Review

As of Q2 2018, Thompson Rubinstein Investment Management held 77 positions worth $299M, up 1.8% from $294M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Trading was light in Q2 2018: portfolio turnover was 0%. Thompson Rubinstein Investment Management opened no new positions and made no exits, leaving the 77-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 27% a quarter earlier, followed by Industrials and Technology.

  • Thompson Rubinstein Investment Management added most to Celgene Corp in Q2 2018, an estimated $922K increase.
  • Thompson Rubinstein Investment Management's biggest Q2 2018 reduction was GE Aerospace, cutting an estimated $528K.
  • Thompson Rubinstein Investment Management's ten largest holdings make up 39% of its $299M portfolio in Q2 2018.
  • Thompson Rubinstein Investment Management opened 0 new positions and closed 0 in Q2 2018.
  • Thompson Rubinstein Investment Management's portfolio value rose 1.8% quarter-over-quarter to $299M.

Based on Thompson Rubinstein Investment Management's 13F filing for Q2 2018, filed 12 Jul 2018.